Efficacy and safety of LM-108, an anti-CCR8 monoclonal antibody, in combination with an anti-PD-1 antibody in patients with gastric cancer: Results from phase 1/2 studies.

Wednesday, June 19, 2024

Dr. Minal Barve

Click the above link to view the abstract and video; a login is required to view the video.

Click here to view the ASCO 2024 Presentation for Trial 22-14.